Nasal COVID-19 vaccine spray could join the market as ENA respiratory begins its phase 1 study the vaccine candidate

AUSTRALIA – ENA Respiratory, a biotechnology company developing a first-in-class nasal spray for the prevention of COVID-19 and other respiratory viral infections, has initiated a Phase I human safety study of INNA-051. The fast-acting and convenient nasal spray has been developed to activate innate immunity in the nose, the primary entry portal of most respiratory viral infections. Ena Respiratory adds that the vaccine could be used prior to or shortly after exposure to a virus, prompting the body to respond faster to protect patients from illness and reduce the chance…

Read More

The pandemic still at large despite India’s slight dip in reported cases of Corona virus

WORLD – According to data released by the Union Health and Family Welfare Ministry, India is witnessing a slight dip in daily reported cases with the last figures standing at 48,698 new cases and 1183 deaths bring a tally of 30,183,143 reported cases. The weekly positivity rate which has been less than 5% for the past 19 days currently has declined to 2.97% as the number of active cases has further declined to 595,565 and now accounts for 1.97 per cent of the total infections with the death toll now…

Read More

Health experts to review heart related complications among teens post their COVID jab

WORLD – A panel of health experts convened by the US health agency will meet to review data surrounding more than 300 confirmed cases of heart inflammation among adolescents and young adults after receiving mRNA COVID vaccines. The committee, hosted by the Centers for Disease Control and Prevention (CDC), will hear a risk-benefit analysis as researchers probe the shots’ probable links to myocarditis, an inflammation of the heart muscle. This emergency review comes after 11, 323 people under the age of 29 who received mRNA COVID vaccines presented to have…

Read More

Pegasus veterans launch new hybrid healthcare agency dubbed Stirred

AUSTRALIA – Senior Pegasus colleagues Jo Spadaccino and Stuart Hehir have launched a new hybrid healthcare agency named Stirred to service clients who want to positively influence health. The agency will offer communications, marketing and creative consultancy to businesses and organizations concerned with the healthcare industry. Spadaccino and Stuart Hehir worked together at Pegasus for 10 years, and both left the firm last summer. They were part of the shareholding team that grew Pegasus from a 20 person, £2m agency to a 140-person, £12m firm, which was acquired by UDG…

Read More